Calviri
Blood & Organ Banks · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
850 N 5th St, Phoenix, Arizona, 85004, U...Phone Number
(480) 205-6436Website
www.calviri.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
2
4
2
1
About Calviri
Calviri is dedicated to ending cancer for both humans and their pets through innovative diagnostics and vaccines. Their flagship product, StageOne Plus, is a multi-cancer blood test that detects cancer at its earliest stages, enabling timely treatment. Additionally, Calviri offers therapeutic and preventative vaccines that target shared tumor antigens, providing affordable and effective cancer care. The company aims to improve the prognosis for both people and dogs, addressing a critical gap in cancer treatment accessibility.Explore more
Calviri Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Calviri your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Calviri had a recent Job posting/layoffs
Product Launch: Get notified when Calviri launches new products
Calviri, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Calviri has new funding data
Website visits: Recent activity has been detected on your website
Check out if Calviri is spiking on competitors!
Check if Calviri has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Calviri
Earning: See what the market has to say on Calviri recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Calviri as Masked Content
Find more new buyers
Compare Similar Companies to Calviri
Compare insights from companies similar to Calviri, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Calviri is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Calviri is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Calviri.
Calviri Tech Stack
A closer look at the technologies used by Calviri
Most Recent Scoops
Person-Based
Person-Based
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Project
Research & Development, Product Management, Medical Research, Clinical Operations
Event
Events
Calviri News & Media
Calviri initiates trial of therapeutic vaccine for early-stage hemangiosarcoma cancer in dogs
First subject vaccinated with investigational vaccine for early-stage hemangiosarcoma in combination with standard treatment Hemangiosarcoma, or HSA, is a common and uniformly fatal cancer in dogs, with particularly high incidence in some popular breeds. PHOENIX, Sept. 30, 2024...Calviri Announces Completion of Groundbreaking Preventative Canine Cancer Vaccine Trial
PHOENIX, June 3, 2024 /PRNewswire/ -- Calviri, Inc. announced the successful conclusion of the Vaccine Against Canine Cancer Study (VACCS) on May 4, 2024; a five-year clinical trial investigating a novel preventative cancer vaccine in dogs. This multi-center, double-blind,...Stan Lapidus Joins Calviri's Scientific Advisory Board
PHOENIX, Oct. 30, 2023 /PRNewswire/ -- Calviri, Inc.— a leading biotech developer of promising new vaccines and diagnostics against cancer - today announced that Stan Lapidus, the founder of Cytyc Corporation and EXACT Sciences, has been elected to join Calviri's Scientific Advisory Board....Calviri Scientists Find New Class of Biomarkers for Predicting Treatment Response in Cancer Patients
Newly observed anti-FSP antibodies also found to predict immune-related adverse events PHOENIX, May 23, 2023 /PRNewswire/ -- Scientists studying immune checkpoint inhibitor (ICI) therapies in advanced lung cancer patients have found that a new class of blood-based biomarkers—...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Calviri
Sign Up For FreeTo access detailed company insights
Calviri is dedicated to ending cancer for both humans and their pets through innovative diagnostics and vaccines. Their flagship product, StageOne Plus, is a multi-cancer blood test that detects cancer at its earliest stages, enabling timely treatment. Additionally, Calviri offers therapeutic and preventative vaccines that target shared tumor antig... Read More
